NewslettersCell Therapy NewsHematopoiesis NewsCD38 as a Pan-Hematologic Target for Chimeric Antigen Receptor T CellsBy Bob - May 15, 20230168In xenografted mice, CART-38-mediated rejection of acute myeloid leukemia, T cell acute lymphoblastic leukemia, and multiple myeloma cell lines and primary samples and prolonged survival.[Blood Advances]Abstract